High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
Hourmant
M
M
Service Néphrologie, University Hospital, Nantes, France.
Buzelin
F
F
Dubigeon
P
P
Soulillou
J P
JP
D000961:Antilymphocyte Serum / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D011897:Random Allocation
D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011241:Prednisone